Convallatoxin is a potent cardiac glycoside within the digitalis class that acts by inhibiting the Na+,K+-ATPase enzyme to exert a positive inotropic effect, often utilized in the management of congestive… Read more
Convallatoxin is a potent cardiac glycoside within the digitalis class that acts by inhibiting the Na+,K+-ATPase enzyme to exert a positive inotropic effect, often utilized in the management of congestive heart failure and specific cardiac arrhythmias. This category provides comprehensive reference standards for Convallatoxin, along with its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These high-quality materials are essential tools for pharmaceutical laboratories performing rigorous analytical testing, method validation, and quality control procedures. By utilizing these precise reference materials, researchers can conduct accurate impurity profiling and quantitative analysis, ensuring compliance with regulatory standards throughout the drug development lifecycle. The inclusion of stable isotope labelled versions further supports the development of robust mass spectrometry-based assays, facilitating the reliable detection and characterization of this compound in complex biological or chemical matrices.